These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15808008)

  • 1. Excretion profile of opiates in dependent patients in relation to route of administration and type of drug measured in urine with immunoassay.
    Taracha E; Habrat B; Chmielewska K; Baran-Furga H
    J Anal Toxicol; 2005; 29(1):15-21. PubMed ID: 15808008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Microgenics CEDIA heroin metabolite (6-AM) and the Roche Abuscreen ONLINE opiate immunoassays for the detection of heroin use in forensic urine samples.
    Holler JM; Bosy TZ; Klette KL; Wiegand R; Jemionek J; Jacobs A
    J Anal Toxicol; 2004 Sep; 28(6):489-93. PubMed ID: 15516301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin.
    Smith ML; Shimomura ET; Summers J; Paul BD; Jenkins AJ; Darwin WD; Cone EJ
    J Anal Toxicol; 2001 Oct; 25(7):504-14. PubMed ID: 11599592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection times and analytical performance of commercial urine opiate immunoassays following heroin administration.
    Smith ML; Shimomura ET; Summers J; Paul BD; Nichols D; Shippee R; Jenkins AJ; Darwin WD; Cone EJ
    J Anal Toxicol; 2000 Oct; 24(7):522-9. PubMed ID: 11043654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forensic drug testing for opiates. V. Urine testing for heroin, morphine, and codeine with commercial opiate immunoassays.
    Cone EJ; Dickerson S; Paul BD; Mitchell JM
    J Anal Toxicol; 1993; 17(3):156-64. PubMed ID: 8336489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
    Huestis MA; Cone EJ; Wong CJ; Umbricht A; Preston KL
    J Anal Toxicol; 2000 Oct; 24(7):509-21. PubMed ID: 11043653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of opiate use in a methadone maintenance treatment population with the CEDIA 6-acetylmorphine and CEDIA DAU opiate assays.
    Spanbauer AC; Casseday S; Davoudzadeh D; Preston KL; Huestis MA
    J Anal Toxicol; 2001 Oct; 25(7):515-9. PubMed ID: 11599593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection time of drugs of abuse in urine.
    Vandevenne M; Vandenbussche H; Verstraete A
    Acta Clin Belg; 2000; 55(6):323-33. PubMed ID: 11484423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Forensic Diagnosis of Very Recent Heroin Intake by 6-acetylmorphine Immunoassay Test and LC-MS/MS Analysis in Urine and Blood.
    Borriello R; Carfora A; Cassandro P; Petrella R
    Ann Clin Lab Sci; 2015; 45(4):414-8. PubMed ID: 26275692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of common opiates and heroin metabolites in urine by high-performance liquid chromatography.
    Low AS; Taylor RB
    J Chromatogr B Biomed Appl; 1995 Jan; 663(2):225-33. PubMed ID: 7735470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the various opiate alkaloid contaminants and their metabolites found in illicit heroin with 6-monoacetyl morphine as indicators of heroin ingestion.
    Paterson S; Cordero R
    J Anal Toxicol; 2006 May; 30(4):267-73. PubMed ID: 16803666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forensic drug testing for opiates. VII. Urinary excretion profile of intranasal (snorted) heroin.
    Cone EJ; Jufer R; Darwin WD; Needleman SB
    J Anal Toxicol; 1996 Oct; 20(6):379-92. PubMed ID: 8889673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrations of unconjugated morphine, codeine and 6-acetylmorphine in urine specimens from suspected drugged drivers.
    Ceder G; Jones AW
    J Forensic Sci; 2002 Mar; 47(2):366-8. PubMed ID: 11908609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical results in urine drug testing for 6-acetylmorphine and total opiates: implications for best analytical strategy.
    Beck O; Böttcher M
    J Anal Toxicol; 2006 Mar; 30(2):73-9. PubMed ID: 16620535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of meconin as a marker for illicit opiate use.
    Morley SR; Forrest AR; Galloway JH
    J Anal Toxicol; 2007 Mar; 31(2):105-8. PubMed ID: 17536746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalization of urinary drug concentrations with specific gravity and creatinine.
    Cone EJ; Caplan YH; Moser F; Robert T; Shelby MK; Black DL
    J Anal Toxicol; 2009; 33(1):1-7. PubMed ID: 19161663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating new marijuana use from residual drug excretion in occasional marijuana users.
    Huestis MA; Cone EJ
    J Anal Toxicol; 1998 Oct; 22(6):445-54. PubMed ID: 9788519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
    Fraser AD; Worth D
    Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results.
    Cone EJ; Sampson-Cone AH; Darwin WD; Huestis MA; Oyler JM
    J Anal Toxicol; 2003 Oct; 27(7):386-401. PubMed ID: 14606991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forensic drug testing for opiates: I. Detection of 6-acetylmorphine in urine as an indicator of recent heroin exposure; drug and assay considerations and detection times.
    Cone EJ; Welch P; Mitchell JM; Paul BD
    J Anal Toxicol; 1991; 15(1):1-7. PubMed ID: 2046334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.